11/17/2023 | Press release | Distributed by Public on 11/17/2023 15:36
Prostate cancer is one of the most common cancers among men, with various treatment options available depending on the stage and aggressiveness of the disease. Prostate brachytherapy with Cesium-131 is a cutting-edge treatment that has gained popularity in recent years. In this blog, we will explore who is a candidate for prostate brachytherapy with Cesium-131 and what this treatment entails.
Understanding Prostate Brachytherapy with Cesium-131
Prostate brachytherapy, also known as seed implantation, is a form of radiation therapy used to treat prostate cancer. In this procedure, tiny radioactive seeds are implanted directly into the prostate gland. These seeds emit radiation, effectively targeting and destroying cancer cells while minimizing damage to surrounding healthy tissue. Cesium-131 is one of the radioactive isotopes commonly used in prostate brachytherapy.
Who is a Candidate for Prostate Brachytherapy with Cesium-131?
Not every prostate cancer patient is a suitable candidate for prostate brachytherapy with Cesium-131. The eligibility criteria typically consider several factors, including:
Consultation with a healthcare provider, specifically a radiation oncologist or urologist, is crucial to determine whether prostate brachytherapy with Cesium-131 is a suitable treatment option. They will assess your medical history, conduct a thorough physical examination, and may perform imaging tests such as MRI or CT scans to determine the extent of the cancer.
Benefits of Prostate Brachytherapy with Cesium-131
For eligible candidates, prostate brachytherapy with Cesium-131 offers several advantages:
Prostate brachytherapy with Cesium-131 is an innovative and effective treatment option for many men with prostate cancer. However, candidacy depends on several factors. It is essential to consult with a qualified healthcare provider to determine if this treatment is suitable for you. If you are a candidate, this approach can offer a targeted and minimally invasive way to combat prostate cancer and improve your quality of life.
Citations:
Benoit RM, Horne ZD, Houser CJ, Smith RP, Beriwal S. Cesium-131 prostate brachytherapy: A single institutional long-term experience. Brachytherapy. 2020 May-Jun;19(3):298-304. doi: 10.1016/j.brachy.2020.02.006. Epub 2020 Apr 2. PMID: 32249178.